巴西快速脓毒症相关器官衰竭评估评分的预测准确性:一项前瞻性多中心研究
该前瞻性多中心研究在巴西纳入两个队列:队列1为急诊和病房中疑似感染但无器官功能障碍或脓毒症的患者(22家医院,5460例),队列2为脓毒症患者(54家医院,4711例),主要终点为院内死亡。队列1中qSOFA≥2预测死亡的敏感性为53.9%(95%CI 50.3-57.5),qSOFA≥1的敏感性为84.9%(95%CI 82.1-87.3),qSOFA≥1或乳酸>2 mmol/L的敏感性为91.3%(95%CI 89.0-93.2),全身炎症反应综合征加器官功能障碍的敏感性为68.7%(95%CI 65.2-71.9)。作者结论认为,在发展中国家qSOFA≥2作为脓毒症筛查工具敏感性低,可能漏诊最终死亡的患者,使用qSOFA≥1或联合乳酸可能提高敏感性。
要点
- 队列1(疑似感染无器官功能障碍或脓毒症,5460例)中qSOFA≥2预测院内死亡的敏感性仅53.9%(95%CI 50.3-57.5)。
- 队列1中qSOFA≥1的敏感性为84.9%(95%CI 82.1-87.3),qSOFA≥1或乳酸>2 mmol/L的敏感性为91.3%(95%CI 89.0-93.2)。
- 队列1中78.3%的患者qSOFA≤1,该组死亡率8.3%(95%CI 7.5-9.1),全体死亡率14.0%(95%CI 13.1-15.0)。
- 队列2(脓毒症,4711例)中62.3%的患者qSOFA≤1,该组死亡率17.3%(95%CI 15.9-18.7);公立医院死亡率39.3%(95%CI 35.5-43.3)。
- 作者结论:qSOFA≥2作为脓毒症筛查工具可能漏诊最终死亡的患者,qSOFA≥1或联合乳酸可能提高敏感性。
适用人群与场景
- 队列1:急诊科和病房中疑似感染但无器官功能障碍或脓毒症的患者,来自22家医院(3家公立、19家私立)。
- 队列2:脓毒症患者,来自54家医院(24家公立、28家私立)。
- qSOFA预测准确性分析仅考虑疑似感染或脓毒症之前的最差值。
诊断标准与关键阈值
- qSOFA评分≥2分作为预测院内死亡的阈值,敏感性53.9%(95%CI 50.3-57.5)。
- qSOFA评分≥1分阈值,敏感性84.9%(95%CI 82.1-87.3)。
- qSOFA评分≥1分或乳酸>2 mmol/L,敏感性91.3%(95%CI 89.0-93.2)。
- 全身炎症反应综合征加器官功能障碍,敏感性68.7%(95%CI 65.2-71.9)。
研究设计与关键结果
- 前瞻性多中心研究,队列1纳入5460例疑似感染无器官功能障碍或脓毒症患者,院内死亡率14.0%(95%CI 13.1-15.0),其中78.3%患者qSOFA≤1(死亡率8.3%,95%CI 7.5-9.1)。
- 队列1中qSOFA≥2预测院内死亡的敏感性53.9%(95%CI 50.3-57.5);qSOFA≥1敏感性84.9%(95%CI 82.1-87.3);qSOFA≥1或乳酸>2 mmol/L敏感性91.3%(95%CI 89.0-93.2);全身炎症反应综合征加器官功能障碍敏感性68.7%(95%CI 65.2-71.9)。
- 队列2纳入4711例脓毒症患者,62.3%患者qSOFA≤1(死亡率17.3%,95%CI 15.9-18.7),公立医院死亡率39.3%(95%CI 35.5-43.3)。
证据类型、等级与局限
- 证据类型:前瞻性多中心研究(临床试验注册号NCT03158493)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在发展中国家qSOFA≥2作为脓毒症筛查工具可能漏诊最终死亡的患者。
- 作者认为,使用qSOFA≥1或qSOFA≥1联合乳酸可能提高筛查敏感性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Although proposed as a clinical prompt to sepsis based on predictive validity for mortality, the Quick Sepsis-related Organ Failure Assessment (qSOFA) score is often used as a screening tool, which requires high sensitivity.Objectives: To assess the predictive accuracy of qSOFA for mortality in Brazil, focusing on sensitivity.Methods: We prospectively collected data from two cohorts of emergency department and ward patients. Cohort 1 included patients with suspected infection but without organ dysfunction or sepsis (22 hospitals: 3 public and 19 private). Cohort 2 included patients with sepsis (54 hospitals: 24 public and 28 private). The primary outcome was in-hospital mortality. The predictive accuracy of qSOFA was examined considering only the worst values before the suspicion of infection or sepsis.Measurements and Main Results: Cohort 1 contained 5,460 patients (mortality rate, 14.0%; 95% confidence interval [CI], 13.1-15.0), among whom 78.3% had a qSOFA score less than or equal to 1 (mortality rate, 8.3%; 95% CI, 7.5-9.1). The sensitivity of a qSOFA score greater than or equal to 2 for predicting mortality was 53.9% and the 95% CI was 50.3 to 57.5. The sensitivity was higher for a qSOFA greater than or equal to 1 (84.9%; 95% CI, 82.1-87.3), a qSOFA score greater than or equal to 1 or lactate greater than 2 mmol/L (91.3%; 95% CI, 89.0-93.2), and systemic inflammatory response syndrome plus organ dysfunction (68.7%; 95% CI, 65.2-71.9). Cohort 2 contained 4,711 patients, among whom 62.3% had a qSOFA score less than or equal to 1 (mortality rate, 17.3%; 95% CI, 15.9-18.7), whereas in public hospitals the mortality rate was 39.3% (95% CI, 35.5-43.3).Conclusions: A qSOFA score greater than or equal to 2 has low sensitivity for predicting death in patients with suspected infection in a developing country. Using a qSOFA score greater than or equal to 2 as a screening tool for sepsis may miss patients who ultimately die. Using a qSOFA score greater than or equal to 1 or adding lactate to a qSOFA score greater than or equal to 1 may improve sensitivity.Clinical trial registered with www.clinicaltrials.gov (NCT03158493).
参考来源
- Machado FR, Cavalcanti AB, Monteiro MB, et al. Predictive Accuracy of the Quick Sepsis-related Organ Failure Assessment Score in Brazil. A Prospective Multicenter Study. Am J Respir Crit Care Med. 2020. PMID: 31910037. doi:10.1164/rccm.201905-0917OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。